Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,817 | 70,971 | 210,518 | 60,063 | 386,569 |
| Marketable Securities | 263,205 | 157,389 | 63,863 | N/A | N/A |
| Receivables | 8,175 | N/A | N/A | N/A | N/A |
| Inventories | 5,212 | N/A | N/A | N/A | N/A |
| TOTAL | $334,295 | $231,726 | $277,700 | $60,730 | $390,656 |
| Non-Current Assets | |||||
| PPE Net | 1,029 | 574 | 329 | 72 | 1,618 |
| Investments And Advances | 5,307 | 0 | 0 | 0 | 0 |
| Intangibles | 7,371 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,151 | 888 | 3,406 | 644 | 2,530 |
| TOTAL | $16,858 | $1,462 | $3,735 | $716 | $4,148 |
| Total Assets | $351,153 | $233,188 | $281,435 | $61,446 | $394,804 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 844 |
| Accounts payable and accrued liabilities | 22,841 | 2,154 | 4,931 | 3,107 | 2,583 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 5,278 |
| Other current liabilities | 557 | N/A | 283 | 1,457 | N/A |
| TOTAL | $23,440 | $2,391 | $5,444 | $8,187 | $9,601 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69,383 | N/A | N/A | 4,930 | N/A |
| Other Non-Current Liabilities | 1,532 | 37 | 3,105 | 3,559 | 2,326 |
| TOTAL | $70,915 | $37 | $3,105 | $8,489 | $2,326 |
| Total Liabilities | $94,355 | $2,428 | $8,549 | $16,676 | $11,927 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,120 | 96,502 | 94,403 | 35,143 | N/A |
| Common Shares | 10 | 10 | 9 | 3 | 3 |
| Retained earnings | -123,305 | -131,303 | -76,938 | -42,256 | -96,734 |
| Other shareholders' equity | 220 | 49 | 407 | 76,039 | 0 |
| TOTAL | $256,798 | $230,760 | $272,886 | $44,770 | $382,877 |
| Total Liabilities And Equity | $351,153 | $233,188 | $281,435 | $61,446 | $394,804 |